Mutual modulation of gut microbiota and the immune system in type 1 diabetes models

View
Author
Date
2023-11-27Permanent link
https://hdl.handle.net/11351/10836DOI
10.1038/s41467-023-43652-x
ISSN
2041-1723
PMID
38012160
Abstract
The transgenic 116C-NOD mouse strain exhibits a prevalent Th17 phenotype, and reduced type 1 diabetes (T1D) compared to non-obese diabetic (NOD) mice. A cohousing experiment between both models revealed lower T1D incidence in NOD mice cohoused with 116C-NOD, associated with gut microbiota changes, reduced intestinal permeability, shifts in T and B cell subsets, and a transition from Th1 to Th17 responses. Distinct gut bacterial signatures were linked to T1D in each group. Using a RAG-2−/− genetic background, we found that T cell alterations promoted segmented filamentous bacteria proliferation in young NOD and 116C-NOD, as well as in immunodeficient NOD.RAG-2−/− and 116C-NOD.RAG-2−/− mice across all ages. Bifidobacterium colonization depended on lymphocytes and thrived in a non-diabetogenic environment. Additionally, 116C-NOD B cells in 116C-NOD.RAG-2−/− mice enriched the gut microbiota in Adlercreutzia and reduced intestinal permeability. Collectively, these results indicate reciprocal modulation between gut microbiota and the immune system in rodent T1D models.
Keywords
Immunological disorders; Metabolic disorders; Molecular biologyBibliographic citation
Rosell-Mases E, Santiago A, Corral-Pujol M, Yáñez F, Varela E, Egia-Mendikute L, et al. Mutual modulation of gut microbiota and the immune system in type 1 diabetes models. Nat Commun. 2023 Nov 27;14:7770.
Audience
Professionals
This item appears in following collections
- VHIR - Articles científics [1751]
The following license files are associated with this item:




